CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 28.84 Min. order: 1 piece ★★★★★ 4.0 (300 reviews) Sold : Login>>
Novo's Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial US$ 21.01 Min. order: 1 piece ★★★★★ 4.5 (131 reviews) Sold : Login>>
Novo Nordisk's experimental obesity drug CagriSema shows blood pressure benefits US$ 27.47 Min. order: 1 piece ★★★★★ 4.7 (91 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 22.90 Min. order: 1 piece ★★★★★ 4.9 (17 reviews) Sold : Login>>
Novo Nosedives on Underwhelming CagriSema Phase III Weight-Loss Data US$ 25.70 Min. order: 1 piece ★★★★★ 4.5 (95 reviews) Sold : Login>>